LEGN · Legend Biotech Corp · Documents
Market Cap
$3.75B
Shares
194.49M
Volume · Oct 23
979.59K
Avg daily vol (3M)
2.3M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2023-04-18 | — | |
| 6-K | — | 2023-04-14 | — | |
| 6-K | — | 2023-04-03 | — | |
| 6-K | — | 2023-03-30 | — | |
| 20-F | — | 2023-03-30 | 2022-12-31 | |
| 6-K | — | 2023-02-17 | 2022-06-30 | |
| 20-F/A | — | 2023-02-17 | 2021-12-31 | |
| 6-K/A | — | 2023-02-17 | 2022-03-31 | |
| 6-K | — | 2023-01-27 | — | |
| 6-K | — | 2023-01-24 | — | |
| 6-K | — | 2023-01-09 | — | |
| 6-K | — | 2023-01-03 | 2023-01-02 | |
| 6-K | — | 2022-12-08 | — | |
| 6-K | — | 2022-11-22 | — | |
| 6-K | — | 2022-11-21 | — | |
| 6-K | — | 2022-11-04 | — | |
| 6-K | — | 2022-11-03 | — | |
| 6-K | — | 2022-10-20 | — | |
| 6-K | — | 2022-10-18 | — | |
| 6-K | — | 2022-10-17 | — | |
| 6-K | — | 2022-10-03 | — | |
| 6-K | — | 2022-09-27 | — | |
| 6-K | — | 2022-09-16 | — | |
| 6-K | — | 2022-09-15 | — | |
| 6-K | — | 2022-08-19 | — | |
| 6-K | — | 2022-08-05 | — | |
| 6-K | — | 2022-08-04 | — | |
| 6-K | — | 2022-07-27 | — | |
| 6-K | — | 2022-07-25 | — | |
| 6-K | — | 2022-07-21 | — | |
| 6-K | — | 2022-07-13 | — | |
| 6-K | — | 2022-07-07 | — | |
| 6-K | — | 2022-06-06 | 2022-06-03 | |
| 6-K | — | 2022-06-03 | — | |
| 6-K | — | 2022-06-02 | 2022-05-31 | |
| 6-K | — | 2022-06-01 | — | |
| 6-K | — | 2022-05-26 | — | |
| 6-K | — | 2022-05-18 | — | |
| 6-K | — | 2022-05-09 | — | |
| 6-K | — | 2022-05-09 | — | |
| 6-K | — | 2022-05-06 | — | |
| 6-K | — | 2022-04-21 | — | |
| 6-K | — | 2022-04-13 | — | |
| 6-K | — | 2022-04-01 | — | |
| 20-F | — | 2022-03-31 | 2021-12-31 | |
| 6-K | — | 2022-03-25 | — | |
| 6-K | — | 2022-03-18 | — | |
| 6-K | — | 2022-03-07 | 2022-03-04 | |
| 6-K | — | 2022-03-01 | 2022-02-28 | |
| 6-K | — | 2022-02-18 | — |
Showing 101–150 of 207 filings
Key facts
CIK
1801198
CUSIP
52490G102
13F (30d)
19 filings
19 filers
Visit website
Investor relations